Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.3760/cma.j.cn112147-20200224-00159

http://scihub22266oqcxt.onion/10.3760/cma.j.cn112147-20200224-00159
suck pdf from google scholar
32294811!ä!32294811
PDF vom PMID32294811  :  Publisher
PDF vom PMID32294811  :  Publisher

suck abstract from ncbi

pmid32294811
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • The keypoints in treatment of the critical coronavirus disease 2019 patient(2) #MMPMID32294811
  • Li XY; Du B; Wang YS; Kang HYJ; Wang F; Sun B; Qiu HB; Tong ZH
  • Zhonghua Jie He He Hu Xi Za Zhi 2020[Apr]; 43 (4): 277-281 PMID32294811show ga
  • The treatment of critically ill patients with coronavirus disease 2019(COVID-19) faces compelling challenges. In this issue, we'd like to share our first-line treatment experience in treating COVID-19. Hemodynamics need be closely monitored and different types of shock should be distinguished. Vasoconstrictor drugs should be used rationally and alerting of complications is of the same importance. The risk of venous thromboembolism (VTE) needs to be assessed, and effective prevention should be carried out for high-risk patients. It is necessary to consider the possibility of pulmonary thromboembolism (PTE) in patients with sudden onset of oxygenation deterioration, respiratory distress, reduced blood pressure. However, comprehensive analysis of disease state should be taken into the interpretation of abnormally elevated D-Dimer. Nutritional support is the basis of treatment. It's important to establish individual therapy regimens and to evaluate, monitor and adjust dynamically. Under the current epidemic situation, convalescent plasma can only be used empirically, indications need to be strictly screened, the blood transfusion process should be closely monitored and the curative effect should be dynamically evaluated.
  • |Betacoronavirus[MESH]
  • |Blood Transfusion[MESH]
  • |Coronavirus Infections/*complications/drug therapy/*therapy[MESH]
  • |Critical Illness[MESH]
  • |Fibrin Fibrinogen Degradation Products/analysis[MESH]
  • |Hemodynamics[MESH]
  • |Humans[MESH]
  • |Nutritional Support[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*complications/*therapy[MESH]
  • |Pulmonary Embolism/diagnosis/prevention & control[MESH]
  • |Shock/diagnosis/therapy[MESH]
  • |Vasoconstrictor Agents/therapeutic use[MESH]
  • |Venous Thromboembolism/diagnosis/prevention & control[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    277 4.43 2020